Revenue: Disclosed revenue for QQ3 2025 is not provided in the data. YoY and QoQ revenue comparisons are not available due to missing quarterly revenue figures.
Operating Income: -$8,017 thousand for QQ3 2025, with YoY decline of approximately -121.0% and QoQ decline of approximately -197.7%.
Net Income: -$8,017 thousand for QQ3 2025, with YoY decline of approximately -121.0% and QoQ decline of approximately -197.7%.
EBITDA: -$8,017 thousand for QQ3 2025.
Cash Flow: Operating cash flow -$3,083 thousand. Change in working capital +$28,220 thousand (positive contributor to cash). Other working capital +$27,406 thousand. Other non-cash items -$23,286 thousand. Net cash from operating activities: -$3,083 thousand.
Financing: Net cash provided by financing activities +$4,500 thousand. Net change in cash: +$1,417 thousand. Cash at end of period: $3,136 thousand; cash at beginning: $1,719 thousand.
Balance Sheet: Total assets $3,136 thousand. Total current liabilities $113,788 thousand. Total liabilities $113,788 thousand. Stockholders’ equity -$110,652 thousand. Cash and cash equivalents: $3,136 thousand.
Key ratios (selected): Current ratio 0.0276; Quick ratio 0.0276; Cash ratio 0.0276. Return on assets -2.56%; Return on equity 7.25% (note: negative equity distorts traditional ROE interpretation). Price-to-book value -8.00; Price-to-earnings -27.62; Enterprise value multiple -110.07; Price-to-sales 0 (data inconsistency across periods). Operating cash flow per share -$0.0000174; Free cash flow per share -$0.0000174.
Notes: All figures are presented in USD thousands unless otherwise stated. The quarter shows substantial negative profitability alongside a fragile balance sheet, with liquidity heavily reliant on financing activity.